John G. Gribben

1989–2025 年に発表

205
論文数
36,358
被引用数
116
h 指数
202
i10 指数

被引用数

John G. Gribben の年別被引用数1991 年: 被引用 2 件1992 年: 被引用 22 件1993 年: 被引用 33 件1994 年: 被引用 121 件1995 年: 被引用 154 件1996 年: 被引用 136 件1997 年: 被引用 87 件1998 年: 被引用 100 件1999 年: 被引用 114 件2000 年: 被引用 99 件2001 年: 被引用 84 件2002 年: 被引用 101 件2003 年: 被引用 111 件2004 年: 被引用 84 件2005 年: 被引用 113 件2006 年: 被引用 97 件2007 年: 被引用 120 件2008 年: 被引用 170 件2009 年: 被引用 179 件2010 年: 被引用 196 件2011 年: 被引用 173 件2012 年: 被引用 206 件2013 年: 被引用 234 件2014 年: 被引用 208 件2015 年: 被引用 328 件2016 年: 被引用 268 件2017 年: 被引用 264 件2018 年: 被引用 319 件2019 年: 被引用 1,001 件2020 年: 被引用 1,249 件2021 年: 被引用 1,247 件2022 年: 被引用 941 件2023 年: 被引用 689 件2024 年: 被引用 1,392 件2025 年: 被引用 606 件2026 年: 被引用 16 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,159 件、この内訳の 27.2%イギリス: 引用元論文 1,242 件、この内訳の 8.1%ドイツ: 引用元論文 1,151 件、この内訳の 7.5%中国: 引用元論文 1,132 件、この内訳の 7.4%イタリア: 引用元論文 922 件、この内訳の 6%フランス: 引用元論文 726 件、この内訳の 4.7%スペイン: 引用元論文 571 件、この内訳の 3.7%カナダ: 引用元論文 498 件、この内訳の 3.3%スイス: 引用元論文 435 件、この内訳の 2.8%オランダ: 引用元論文 407 件、この内訳の 2.7%オーストラリア: 引用元論文 406 件、この内訳の 2.7%日本: 引用元論文 328 件、この内訳の 2.1%
0%27.2%その他 21.8%

分野

  • Medicine65.4%
  • Biochemistry, Genetics and Molecular Biology18%
  • Immunology and Microbiology14.2%
  • Neuroscience0.5%
  • Engineering0.4%
  • Computer Science0.3%
  • その他1.2%

トピック

  • Lymphoma Diagnosis and Treatment9%
  • Chronic Lymphocytic Leukemia Research7.1%
  • Immune Cell Function and Interaction5.9%
  • CAR-T cell therapy research5.5%
  • T-cell and B-cell Immunology3.3%
  • Immunotherapy and Immune Responses3.2%
  • その他66%

共著者

全論文

検索で開く
  1. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeffrey I. Cohen, Francesco d’Amore, Andrew Davies, Brunangelo Falini, Irene M. Ghobrial, John R. Goodlad, John G. Gribben, Eric D. Hsi, Brad S. Kahl, Won-Seog Kim, Shaji Kumar, Ann S. LaCasce, Camille Laurent, Georg Lenz, John P. Leonard, Michael P. Link, Armando López‐Guillermo, María‐Victoria Mateos, Elizabeth Macintyre, Ari Melnick, Franck Morschhauser, Shigeo Nakamura, Marina Narbaitz, Astrid Pavlovsky, Stefano Pileri, Miguel Á. Piris, Barbara Pro, S. Vincent Rajkumar, Steven T. Rosen, Birgitta Sander, Laurie H. Sehn, Margaret A. Shipp, Sonali M. Smith, Louis M. Staudt, Catherine Thieblemont, Thomas Tousseyn, Wyndham H. Wilson, Tadashi Yoshino, Pier Luigi Zinzani, Martin Dreyling, David W. Scott, Jane N. Winter, Andrew D. Zelenetz - Blood 2022 被引用: 1,506

  2. Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Catherine Thiéblemont, Max S. Topp, Pier Luigi Zinzani, John G. Gribben, Chiara Bonini, Anna Sureda, Ibrahim Yakoub‐Agha - Blood 2023 被引用: 311

  3. Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , D. Chen, Radovan Vrḫovac, John G. Gribben, Nicolaus Kröger, Hermann Einsele, Ibrahim Yakoub‐Agha - Annals of Oncology 2021 被引用: 422

  4. Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrew Clear, John G. Gribben, Evelyn Nguyen, Magdalena Czader, Sarah L. Ondrejka, Angela M. B. Collie, Eric D. Hsi, Eric Tse, Rex Au-Yeung, Yok‐Lam Kwong, Gopesh Srivastava, William W.L. Choi, Andrew M. Evens, Monika Pilichowska, Manju Sengar, Nishitha Reddy, Shaoying Li, Amy Chadburn, Leo I. Gordon, Elaine S. Jaffe, Shawn Levy, Rachel E. Rempel, Tiffany J. Tzeng, Lanie E. Happ, Tushar Dave, Deepthi Rajagopalan, Jyotishka Datta, David B. Dunson, Sandeep S. Davé - Cell 2017 被引用: 1,146

  5. Bone marrow niches in haematological malignancies

    著者: , , , , , , , - Nature reviews. Cancer 2020 被引用: 468

  6. Activated Pancreatic Stellate Cells Sequester CD8+ T Cells to Reduce Their Infiltration of the Juxtatumoral Compartment of Pancreatic Ductal Adenocarcinoma

    著者: , , , , , , , , , , , - Gastroenterology 2013 被引用: 566

  7. Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Piers Patten, Peter Hillmen - New England Journal of Medicine 2023 被引用: 155

  8. AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma

    著者: , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 被引用: 421

  9. Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yuhong Fan, Rudolf Grosschedl, Claude Chelala, Jude Fitzgibbon - Nature Genetics 2013 被引用: 731

  10. Pancreatic Cancer Chemotherapy Is Potentiated by Induction of Tertiary Lymphoid Structures in Mice

    著者: , , , , , , , , , , - Cellular and Molecular Gastroenterology and Hepatology 2021 被引用: 102

  11. Deconstruction of a Metastatic Tumor Microenvironment Reveals a Common Matrix Response in Human Cancers

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2017 被引用: 354

  12. Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2018 被引用: 548

  13. T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production

    著者: , , , , , , , - Blood 2012 被引用: 527

  14. Genomic profiling for clinical decision making in lymphoid neoplasms

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Falko Fend, Philippe Gaulard, Paolo Ghia, John G. Gribben, Olivier Hermine, Daniel J. Hodson, Eric D. Hsi, Giorgio Inghirami, Elaine S. Jaffe, Kennosuke Karube, Keisuke Kataoka, Wolfgang Hiddemann, Won Seog Kim, Rebecca L. King, Young Hyeh Ko, Ann S. LaCasce, Georg Lenz, José I. Martín‐Subero, Miguel Á. Piris, Stefania Pittaluga, Laura Pasqualucci, Leticia Quintanilla‐Martínez, Scott J. Rodig, Andreas Rosenwald, Gilles Salles, Jesús F. San Miguel, Kerry J. Savage, Laurie H. Sehn, Gianpietro Semenzato, Louis M. Staudt, Steven H. Swerdlow, Constantine S. Tam, Judith Trotman, Julie M. Vose, Oliver Weigert, Wyndham H. Wilson, Jane N. Winter, Catherine J. Wu, Pier Luigi Zinzani, Emanuele Zucca, Adam Bagg, David W. Scott - Blood 2022 被引用: 161

  15. The EBMT/EHA CAR-T Cell Handbook

    著者: , , , , - 2022 被引用: 93

  16. Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: The CLARITY Study

    著者: , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 被引用: 271

  17. First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE trial

    著者: , , , , , , , , , , , , , , , - Haematologica 2022 被引用: 130

  18. Chronic lymphocytic leukaemia

    著者: , , , , , , , , - Nature Reviews Disease Primers 2017 被引用: 509

  19. Mechanisms of Action of Lenalidomide in B-Cell Non-Hodgkin Lymphoma

    著者: , , - Journal of Clinical Oncology 2015 被引用: 296

  20. Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philippe Gaulard, Gilles Salles, Catherine Burton, Daphne de Jong, Laurie H. Sehn, Delphine Maucort‐Boulch - Journal of Clinical Oncology 2019 被引用: 254

  21. Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug

    著者: , , , , , , , - Journal of Clinical Investigation 2008 被引用: 594

  22. EZH2 mutations are frequent and represent an early event in follicular lymphoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexander Kohlmann, Torsten Haferlach, Randy D. Gascoyne, Jude Fitzgibbon - Blood 2013 被引用: 323

  23. Increased Vascular Permeability in the Bone Marrow Microenvironment Contributes to Disease Progression and Drug Response in Acute Myeloid Leukemia

    著者: , , , , , , , , , , , , - Cancer Cell 2017 被引用: 245

  24. Peripheral blood T cells in acute myeloid leukemia (AML) patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blasts

    著者: , , , , , , , , - Blood 2009 被引用: 240